Back

Polygenic risk score as a predictor of coronary artery disease severity and plaque features in CCTA

31 August 2026 (09:15 - 10:00)
Organised by: Logo
Congress Presentation Part of: Plaque characterisation and disease progression on cardiac computed tomography angiography Plaque Imaging ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Saima Mushtaq

Monzino Cardiology Centre, Milan (Italy)

4 More presentations in this session

Presentation thumbnail
Plaque composition in symptomatic versus asymptomatic women and men: data from the CONFIRM2 registry
Doctor S. Cramer (Amsterdam, NL)
Abstract
Presentation thumbnail
High Lipoprotein(a) levels and coronary plaque burden: 175 nmol/L as a potential target for early CT-based risk assessment
Associate Professor P. Breitbart (Frankfurt am Main, DE)
Abstract
Presentation thumbnail
PCSK9i and atherosclerotic plaque regression assessed by coronary computed tomography angiography
Doctor M. Sagris (Athens, GR)
Abstract
Presentation thumbnail
Effects of statin treatment on coronary plaque morphology: longitudinal radiomics-based precision phenotyping using coronary computed tomography angiography
Mr J. Stewart (Melbourne, AU)
Abstract

Access the full session

Session thumbnail
Plaque characterisation and disease progression on cardiac computed tomography angiography

The Event

Event poster

ESC Congress 2026

31 August 2026 09:15 CET
You may be interested in
thumbnail
Congress Presentation
Association of coronary artery calcium score groups with qualitative and quantitatively assessed adverse plaque
28 August 2021
thumbnail
Webinar
Polygenic risk scores: what is their value for risk prediction and potential for clinical utility?
22 March 2022
thumbnail
Congress Presentation
Impact of Coronary CT angiography in combination with CAD-RADS on the management of coronary artery disease patients
11 December 2020
thumbnail
Congress Presentation
Correlation of coronary artery geometry with the complexity and severity of coronary atherosclerosis: rationale and design of the GEOMETRY-CTA study
9 May 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources